125 related articles for article (PubMed ID: 17502119)
1. ATM missense variant P1054R predisposes to prostate cancer.
Meyer A; Wilhelm B; Dörk T; Bremer M; Baumann R; Karstens JH; Machtens S
Radiother Oncol; 2007 Jun; 83(3):283-8. PubMed ID: 17502119
[TBL] [Abstract][Full Text] [Related]
2. ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer.
Cesaretti JA; Stock RG; Lehrer S; Atencio DA; Bernstein JL; Stone NN; Wallenstein S; Green S; Loeb K; Kollmeier M; Smith M; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):196-202. PubMed ID: 15629612
[TBL] [Abstract][Full Text] [Related]
3. A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy.
Cesaretti JA; Stock RG; Atencio DP; Peters SA; Peters CA; Burri RJ; Stone NN; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1410-6. PubMed ID: 17490827
[TBL] [Abstract][Full Text] [Related]
4. Risk of cancer by ATM missense mutations in the general population.
Dombernowsky SL; Weischer M; Allin KH; Bojesen SE; Tybjaerg-Hansen A; Nordestgaard BG
J Clin Oncol; 2008 Jun; 26(18):3057-62. PubMed ID: 18565893
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer in female carriers of ATM gene alterations: outcome of adjuvant radiotherapy.
Meyer A; John E; Dörk T; Sohn C; Karstens JH; Bremer M
Radiother Oncol; 2004 Sep; 72(3):319-23. PubMed ID: 15450731
[TBL] [Abstract][Full Text] [Related]
6. Histopathological features of breast cancer in carriers of ATM gene variants.
Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA
Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
[TBL] [Abstract][Full Text] [Related]
7. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
[TBL] [Abstract][Full Text] [Related]
8. Contribution of mutations in ATM to breast cancer development in the Czech population.
Soukupova J; Dundr P; Kleibl Z; Pohlreich P
Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
Dörk T; Bendix R; Bremer M; Rades D; Klöpper K; Nicke M; Skawran B; Hector A; Yamini P; Steinmann D; Weise S; Stuhrmann M; Karstens JH
Cancer Res; 2001 Oct; 61(20):7608-15. PubMed ID: 11606401
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of ATM missense variants and their contribution to contralateral breast cancer.
Broeks A; Braaf LM; Huseinovic A; Schmidt MK; Russell NS; van Leeuwen FE; Hogervorst FB; Van 't Veer LJ
Breast Cancer Res Treat; 2008 Jan; 107(2):243-8. PubMed ID: 17393301
[TBL] [Abstract][Full Text] [Related]
11. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
Lehrer S; Cesaretti J; Stone NN; Stock RG
BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
[TBL] [Abstract][Full Text] [Related]
12. ATM polymorphism IVS62+60G>A is not associated with disease aggressiveness in prostate cancer.
Browning RE; Li H; Shinohara ET; Cai Q; Chen H; Courtney R; Cao C; Zheng W; Lu B
Urology; 2006 Jun; 67(6):1320-3. PubMed ID: 16765197
[TBL] [Abstract][Full Text] [Related]
13. ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.
Brunet J; Gutiérrez-Enríquez S; Torres A; Bérez V; Sanjosé S; Galceran J; Izquierdo A; Menéndez JA; Gumà J; Borràs J
Clin Genet; 2008 May; 73(5):465-73. PubMed ID: 18384426
[TBL] [Abstract][Full Text] [Related]
14. Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors.
Lu S; Shen K; Wang Y; Santner SJ; Chen J; Brooks SC; Wang YA
Carcinogenesis; 2006 Apr; 27(4):848-55. PubMed ID: 16400190
[TBL] [Abstract][Full Text] [Related]
15. Two ATM variants and breast cancer risk.
Thompson D; Antoniou AC; Jenkins M; Marsh A; Chen X; Wayne T; Tesoriero A; Milne R; Spurdle A; Thorstenson Y; Southey M; Giles GG; Khanna KK; Sambrook J; Oefner P; Goldgar D; Hopper JL; Easton D; Chenevix-Trench G;
Hum Mutat; 2005 Jun; 25(6):594-5. PubMed ID: 15880680
[TBL] [Abstract][Full Text] [Related]
16. Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia.
Meier M; den Boer ML; Hall AG; Irving JA; Passier M; Minto L; van Wering ER; Janka-Schaub GE; Pieters R
Leukemia; 2005 Nov; 19(11):1887-95. PubMed ID: 16167060
[TBL] [Abstract][Full Text] [Related]
17. Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.
Spring K; Ahangari F; Scott SP; Waring P; Purdie DM; Chen PC; Hourigan K; Ramsay J; McKinnon PJ; Swift M; Lavin MF
Nat Genet; 2002 Sep; 32(1):185-90. PubMed ID: 12195425
[TBL] [Abstract][Full Text] [Related]
18. ATM variants and cancer risk in breast cancer patients from Southern Finland.
Tommiska J; Jansen L; Kilpivaara O; Edvardsen H; Kristensen V; Tamminen A; Aittomäki K; Blomqvist C; Børresen-Dale AL; Nevanlinna H
BMC Cancer; 2006 Aug; 6():209. PubMed ID: 16914028
[TBL] [Abstract][Full Text] [Related]
19. Detection of ATM gene mutations in young lung cancer patients: a population-based control study.
Schneider J; Illig T; Rosenberger A; Bickeböller H; Wichmann HE
Arch Med Res; 2008 Feb; 39(2):226-31. PubMed ID: 18164969
[TBL] [Abstract][Full Text] [Related]
20. ATM and breast cancer susceptibility.
Ahmed M; Rahman N
Oncogene; 2006 Sep; 25(43):5906-11. PubMed ID: 16998505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]